What's breaking now, across thousands of outlets.
Moonwalk Biosciences is heading to the clinic with an obesity program and has raised $70 million for that goal, leaning into a shift in its approach to using genetic medicine. The company, founded by former ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
New financing will help Moonwalk Biosciences expand its pipeline of siRNA medicines targeting adipose tissue while building out its proprietary drug discovery platform.
As people lose health insurance coverage, experts warn of more crowded hospitals and higher costs for everyone.
Senegal’s locally manufactured hydroxyurea, alongside Nigeria’s sickle-cell research, is strengthening Africa’s response to a disease that disproportionately affects the continent—but access…
Public health guidelines usually tell us to "move more," but new research shows context matters. A sweeping study finds recreational exercise protects against dementia, but physical labor at work…
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.
[Daily Trust] Plateau State Governor, Caleb Mutfwang, has directed the immediate mobilisation of drugs and other medical commodities to health facilities handling patients affected by the diphtheria…
